Results 11 to 20 of about 866,934 (50)
Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition [PDF]
A Akcakanat, A Prat, AC Matin, Adam L Cohen, AH Bild, AL Cohen, AM Gonzalez-Angulo, Andrea H Bild, B Marty, B Rubio-Viqueira, B Weigelt, Banafshe Larijani, BD Lehmann, BD Manning, C Gewinner, C O’Brien, CA Schneider, Caroline M Piskun, CG Fedele, CJ Creighton, CM Perou, DA Guertin, DA Guertin, DA Krueger, Daniel O Frimannsson, E López-Knowles, E Marangoni, F Bertucci, F Janku, F Meric-Bernstam, F Reyal, Frederick M Dirbas, Gennadi V Glinsky, Glenn Deng, Haiyu Zhang, HH Fiebig, I Mayer, Irene L Wapnir, J Baselga, J Chung, J Lamb, J LoPiccolo, J Ma, JC Montero, JC Singh, K Hara, K Inoki, K Stemke-Hale, KE Valdez, KG Foster, L Ding, LA Petrillo, LH Saal, M Bärlund, M Hidalgo, M Kyndi, M Laplante, M Smid, Marc A Coram, MD Landis, ME Feldman, ME Pavel, Melinda L Telli, Michael Herrler, P Cottu, P Kabos, P Malaney, Q Zeng, R Dent, R Edgar, R Soldi, R Watanabe, RJ Motzer, S Badve, S Hart, S Xu, SA Moestue, Selvaraju Veeriah, Shanaz H Dairkee, SL Ellard, SP Shah, Stefanie S Jeffrey, Sujatha Krishnakumar, T Sørlie, Teri A Longacre, The Cancer Genome Atlas Network, TW Miller, X Chen, X Zhang, X Zhou, Y Gökmen-Polar, YS DeRose, Z Hu +92 morecore +1 more sourceSilencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo [PDF]
A Khurana, A Khurana, A Khurana, A Locatelli, A Planche, AM Brown, Ashwani Khurana, B Fisher, B Fisher, CC Chua, ES Radisky, F Moinfar, F Yotsumoto, F Yotsumoto, FR Miller, H Lemjabbar-Alaoui, Hiedi McKean, HJ Burstein, Hyunseok Kim, I Ota, J Lai, Jacie Mcguire, JP Lai, JP Lai, JP Lai, K Narita, K Narita, KC Nannuru, L Wiechmann, Lewis R Roberts, LR Tait, M Bernfield, M Morimoto-Tomita, M Morimoto-Tomita, M Sharma, Matthew P Goetz, MC Abba, MP Shekhar, PR Pandey, R Nawroth, R Sharpe, S Otsuki, SM Peterson, Sung-Hoon Kim, Viji Shridhar, WG Stetler-Stevenson, YG Zhao +46 morecore +1 more sourceTumor senescence and radioresistant tumor-initiating cells (TICs): let sleeping dogs lie! [PDF]
AM McCord, C Lagadec, F Karimi-Busheri, Gaetano Zafarana, H Bartelink, H Suit, M Collado, M Diehn, M Hamburg, M Zhang, MS Moran, R Roy, RG Bristow, Robert G Bristow, RP Bristow RG Hill, RP Hill, RP Hill, S Bao, S Liu, TM Phillips, U Koch, WA Woodward, WA Woodward +22 morecore +1 more sourceFood choice and phytoestrogen consumption in women previously treated for postmenopausal breast cancer [PDF]
BM Parry, Committee on Toxicology of Chemicals in Food, Consumer Products and the Environment, DB Clarke, E Mills, H Adlercreutz, JE Brown, JM Lawrence, JM Stilwell, L Storey, M De Lemos, M Raats, RM Rainsbury, SM Horton +12 morecore +1 more sourceBreastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers [PDF]
AI Phipps, Aletta Poll, Andrea Eisen, Charis Eng, Charmaine Kim-Sing, Christian Singer, Collaborative Group on Hormonal Factors in Breast Cancer, E Lee, H Jernstrom, H Jernstrom, H Vidarsson, Henry T Lynch, J Chang-Claude, J Gronwald, J Kotsopoulos, J Russo, J Russo, Jan Lubinski, JD Kark, Joanne Blum, Joanne Kotsopoulos, JR Palmer, JV Rajan, JV Rajan, L Bernstein, L Lipworth, L Tryggvadottir, Leigha Senter, Leonardo Salmena, MA Brown, MC Pike, ML Asselin-Labat, N Andrieu, N Mavaddat, Nadine Tung, Ophira Ginsburg, PA Joshi, Parviz Ghadirian, Peter Ainsworth, Ping Sun, RC Millikan, Rochelle Demsky, ST Marquis, Steven A Narod, Susan L Neuhausen, TJ Key, Tomasz Huzarski, WD Foulkes, William D Foulkes, X Xu +49 morecore +1 more sourceDirect repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells [PDF]
A Barrallo-Gimeno, A Eger, A Hammacher, AA Postigo, AA Postigo, AM Quintana, AR Thorner, B Dave, B Tanno, Boris Sarcevic, Bryce JW van Denderen, C Kudo-Saito, CA Rubio, Cletus Pinto, D Skalamera, DA Mayes, DM Dykxhoorn, Donald F Newgreen, Eliza TL Soo, Erik W Thompson, F Hu, F Hu, F Valdes, G Browne, G Fontemaggi, GY Lee, GY Perret, H Hugo, H Hugo, H Peinado, HJ Hugo, HJ Hugo, Honor J Hugo, J Malaterre, J Yang, JH Taube, JL Yori, K Aigner, K Aigner, K Aokage, K Kurima, KA Kaproth-Joslin, L Knopfova, Lloyd Pereira, M Escriva, M Jo, M Labelle, M Pieraccioli, MA Nieto, ML Ackland, ML Ackland, N Gavert, N P A Devika Gunasinghe, NA Franken, NA Said, NC Nicolaides, NPAD Gunasinghe, OA Kent, PE Goss, PJ Kowalski, Prue Hill, Randy Suryadinata, RD Lester, RG Ramsay, RH Whitehead, RH Whitehead, RH Whitehead, RM Neve, Robert G Ramsay, RY Miao, S Spaderna, S Spaderna, S Valastyan, SA Mani, SC Barry, T Blick, T Blick, Thomas J Gonda, U Burk, V Cesi, V Karafiat, V Vichai, W Voigt, W Xia, X Zong, Y Drabsch, Y Drabsch, Y Wu, Y Zhou, YH Ahn, YL Chao, Yvette Drabsch, Z Hu +92 morecore +1 more sourceIntegrative analyses of gene expression and DNA methylation profiles in breast cancer cell line models of tamoxifen-resistance indicate a potential role of cells with stem-like properties [PDF]
A Dowejko, A Hurtado, A Ring, A Subramanian, AE Lykkesfeldt, AE Lykkesfeldt, Anne E Lykkesfeldt, BB Rasmussen, BE Bernstein, BL Brockdorff, C Davies, C O’Brien, C Scheel, CK Osborne, Daniel Elias, EA Musgrove, F Krueger, G Dontu, G Perez-Tenorio, GM Clark, Guangliang Yin, H Heyn, H Li, HD Soule, Henrik J Ditzel, Huanming Yang, IA Ivanova, J Li, J Sastre-Serra, J Wong, J Xu, Jan Stenvang, Jian Li, JT Robinson, Jun Wang, K Takahashi, KA Becker, KJ Livak, L Topol, Lars Bolund, M Al-Hajj, M Dean, M Fan, M Ghoussaini, M Lippman, M Lupien, M Shipitsin, MA Augello, MC Alles, MF Gjerstorff, ML Talman, MW Madsen, N Brunner, N Brunner, Nils Brünner, O Leis, OW Petersen, P Bernard, P Briand, P de Cremoux, P Sansone, Qian Zhao, R Clarke, R Clarke, S Pancholi, S Tempel, S Thrane, SL Kong, SM Nabha, T Frogne, T Frogne, T van Agthoven, V Lefebvre, VC Jordan, X Fu, Xue Lin, Y Chen, Z Li +77 morecore +1 more sourceFGFR1 is amplified during the progression of in situto invasive breast carcinoma [PDF]
A Bergamaschi, A Letessier, A Vincent-Salomon, AE Place, B Erbas, BE Welm, C Corzo, C Theillet, CB Moelans, CB Vos, CJ Ormandy, CL Hyun, CM Schlotter, DC Allred, DJ Slamon, EC Robanus-Maandag, EK Latta, ES Hwang, Eun Joo Kim, Eunyoung Kang, F Courjal, F Courjal, F Ugolini, H Buerger, Hee Eun Lee, In Ah Kim, J Adelaide, J Xu, J Yao, Jee Hyun Kim, K Park, KD Voduc, KL Streicher, L Burkhardt, L Hernandez, M Hu, ME Hammond, MF Press, Min Hye Jang, MW Beckmann, N Turner, S Aulmann, S Elbauomy Elsheikh, S Glockner, SL Deming, SM Rodriguez-Pinilla, So Yeon Park, Sung-Won Kim, V Baldin, V Gelsi-Boyer, VP Eswarakumar, W Xian, XJ Ma, Y Choi, Y Nikolsky, Yoomi Choi, Yu Jung Kim, ZQ Yang +57 morecore +1 more sourcePIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients [PDF]
AG Dumont, Andrew D Vincent, B Fisher, CRC Adjuvant Breast Trial Working Party, CW Elston, Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Els MJJ Berns, F Buttitta, F Janku, G Peiro, G Perez-Tenorio, H Hartog, I Vivanco, IG Campbell, J Baselga, Jan B Vermorken, JB Vermorken, Jelle Wesseling, Jettie J Muris, JH Law, JM Gee, JM Knowlden, K Beelen, K Beelen, K Kalinsky, K Stemke-Hale, Karin Beelen, KE O’Reilly, KL Henriksen, KM Vasudevan, LE Rutqvist, LH Saal, LM McShane, M Barbareschi, M Cizkova, M Dowsett, M Dowsett, M Kok, Mark Opdam, MJ Ellis, N Maruyama, Paul J van Diest, Q Li, R Michalides, R Parsons, RA Campbell, Rutger HT Koornstra, S Loi, Sabine C Linn, SJ Isakoff, T Bachelot, T Iwamoto, Tesa M Severson, The Cancer Genome Atlas Network, TJ Dekker, VS Sabine, Y Zhang, Z Sangale +57 morecore +1 more source
